Ticker: VRCA

Company: Verrica Pharmaceuticals Inc.

Person: Christopher G Hayes, officer

Transaction date: March 14, 2025

Reporting date: March 18, 2025

Average share price: 0.65

Sold 4315.0 shares for 2804.75